Literature DB >> 2793577

Rheumatoid arthritis subsequent to Borrelia burgdorferi infection in two dogs.

J K Roush1, P A Manley, R T Dueland.   

Abstract

Two dogs with clinical signs of polyarthritis developed rheumatoid arthritis subsequent to Borrelia burgdorferi infection. In both dogs, the diagnosis of B burgdorferi infection was based on clinical signs of disease and high serum B burgdorferi titer. After antibiotic administration, both dogs had decreased B burgdorferi titer, but clinical response was temporary or was lacking. The dogs subsequently were rheumatoid factor-positive (antinuclear antibody- and anti-globulin-negative) and responded to anti-inflammatory drug administration. Development of rheumatoid arthritis in both dogs after B burgdorferi infection implicates the Borrelia organism as an infective agent leading to the development of rheumatoid arthritis in dogs. Dogs with clinical signs suggestive of B burgdorferi infection should have antiglobulin, anti-nuclear antibody rheumatoid factor, and B burgdorferi tests performed to aid definitive diagnosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2793577

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

1.  Interlaboratory comparison of titers of antibody to Borrelia burgdorferi and evaluation of a commercial assay using canine sera.

Authors:  R T Greene; D A Hirsch; P L Rottman; T M Gerig
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

2.  Seroepidemiological studies of Borrelia burgdorferi infection in sheep in Norway.

Authors:  V Fridriksdóttir; L L Nesse; R Gudding
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

3.  Serological studies on the infection of dogs in Ontario with Borrelia burgdorferi, the etiological agent of Lyme disease.

Authors:  H Artsob; I K Barker; R Fister; G Sephton; D Dick; J A Lynch; D Key
Journal:  Can Vet J       Date:  1993-09       Impact factor: 1.008

4.  Improvement of common variable immunodeficiency using embryonic stem cell therapy in a patient with lyme disease: a clinical case report.

Authors:  Richard Horowitz; Phyllis R Freeman
Journal:  Clin Case Rep       Date:  2018-05-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.